Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
BNY Mellon International Equity A NIEAX
- NAV / 1-Day Return 22.29 / +0.50 %
- Total Assets 324.1 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.070%
- Distribution Fee Level Below Average
- Share Class Type Front Load
- Category Foreign Large Blend
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Closed
- TTM Yield 1.80%
- Turnover 46%
USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:19 PM GMT+0
Morningstar’s Analysis NIEAX
Will NIEAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Nestle SA | 3.85 | 12.4 Mil | Consumer Defensive |
ASML Holding NV | 3.67 | 11.8 Mil | Technology |
Novo Nordisk A/S Class B | 3.10 | 9.9 Mil | Healthcare |
Novartis AG Registered Shares | 2.94 | 9.4 Mil | Healthcare |
Lvmh Moet Hennessy Louis Vuitton SE | 2.93 | 9.4 Mil | Consumer Cyclical |
SAP SE | 2.79 | 9.0 Mil | Technology |
AstraZeneca PLC | 2.65 | 8.5 Mil | Healthcare |
RELX PLC | 2.37 | 7.6 Mil | Industrials |
Sanofi SA | 2.26 | 7.3 Mil | Healthcare |
Wolters Kluwer NV | 2.22 | 7.1 Mil | Industrials |